search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
123 new news items in the last 24 hours
  1. Home
  2. Health

A global clinical study is testing a preventive vaccine for lung cancer, targeting individuals at high risk, with the aim of identifying and early eliminating abnormal cells.

Radu Burcă
whatsapp
facebook
linkedin
x
copy-link copy-link
27 November 2025, 16:38
main event image
Health
Foto: pexels.com
google-preference

Always see our news on Google

Lung cancer remains a lethal form of cancer, and its prevention is essential. A clinical study, launched by University College London and the University of Oxford, is testing an experimental vaccine called LungVax, aimed at individuals at high risk of lung cancer. Its goal is to induce an immune response that recognizes and eliminates lung cells with tumor changes before the disease manifests. The study, funded with over 2.3 million euros, will assess the safety and optimal dose of the vaccine, with a planned launch for the summer of 2026.

The vaccine is based on the identification of neoantigens, abnormal proteins expressed by cancer cells, which can be recognized by the immune system. In the first phase, the vaccine will be tested on individuals with early-stage lung cancer and on participants from the national screening program. If the results are favorable, the study will be expanded to assess the utility of the vaccine as a large-scale preventive strategy. In the United Kingdom, approximately 48,500 cases of lung cancer are reported annually, most of which are associated with smoking. The vaccine could complement existing preventive measures, providing a new approach in the fight against this devastating disease.

Sources

sursa imagine
News.ro
Primul vaccin experimental pentru prevenirea cancerului pulmonar, testat în premieră mondială
sursa imagine
Spotmedia
S-a descoperit un potențial factor declanșator al cancerului pulmonar. Boala poate fi prevenită!

Latest News

10:26

The stakes of Nicușor Dan's visit to New York. The President will lead Romania's delegation to the 81st session of the UN General Assembly.

10:15

Emmanuel Macron will receive the Saudi crown prince on Sunday and Monday. They will discuss regional stakes and bilateral cooperation.

09:57

The year 2027 could be the hottest year ever recorded due to the intensification of the El Nino phenomenon.

09:36

Drone attack at the border between Ukraine and the Republic of Moldova / Tabachi crossing point damaged

09:24

21 August 2026. TV: What was discussed last night on the news channels

See more news

NEWS ON THE SAME TOPICS

event image
Health
An experimental injection against cancer completely eliminated tumors in patients who did not respond to chemotherapy or immunotherapy.
event image
International
An experimental cancer vaccine, developed by Moderna and Merck, has shown promising results in patients with melanoma.
event image
EU
A project funded by the European Union is testing 100,000 children for the early detection of type 1 diabetes.
event image
Health
Researchers are testing stem cells from umbilical cord for the prevention of brain injuries in premature babies.
event image
Health
WHO begins clinical study for an antiviral drug against Ebola
event image
EU
The European Union finances 58 projects for reducing inequalities in the prevention and treatment of cancer.
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
study clinical trials lung cancer london cancer cells

Editor’s Recommendations

main event image
Exclusive
1 hour ago
Original Content

21 August 2026. TV: What was discussed last night on the news channels

main event image
Politics
2 hours ago

The interim Minister of Labor, Dragoș Pîslaru, about the Salary Law: "We have explored all possible options to achieve social acceptability, respecting the fiscal-budgetary reality of Romania."

Sources
imagine sursa
imagine sursa
main event image
International
2 hours ago

The nuclear power plant at Kozloduy, Bulgaria, is reducing capacity due to the low water level in the Danube.

Sources
imagine sursa
imagine sursa
imagine sursa
imagine sursa
imagine sursa
+11
main event image
Opinions
Yesterday 08:35

Andrei Pleșu: About public speaking

app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol